Mostra el registre d'ítem simple

dc.contributor.authorMorejon Alonso, lizette
dc.contributor.authorDelgado Garcia-Menocal, Jose Angel
dc.contributor.authorTarrago Aymerich, Mariona
dc.contributor.authorAlvarez Guichard, Julio Andres
dc.contributor.authorGarcía-Vallès, Maite
dc.contributor.authorMartínez Manent, Salvador
dc.contributor.authorGinebra Molins, Maria Pau
dc.contributor.otherUniversitat Politècnica de Catalunya. Departament de Ciència dels Materials i Enginyeria Metal·lúrgica
dc.date.accessioned2014-04-28T11:15:01Z
dc.date.created2014-02-01
dc.date.issued2014-02-01
dc.identifier.citationMorejon, L. [et al.]. Calcium phosphate glasses: Silanation process and effect on the bioactivity behavior of Glass-PMMA composites. "Journal of biomedical materials research. Part B, Applied biomaterials", 01 Febrer 2014, vol. 102, núm. 2, p. 205-213.
dc.identifier.issn1552-4973
dc.identifier.urihttp://hdl.handle.net/2117/22721
dc.description.abstractThis article presents the results of a study of the efficiency of silanation process of calcium phosphate glasses particles and its effect on the bioactivity behavior of glass- poly(methyl methacrylate) (PMMA) composites. Two different calcium phosphate glasses: 44.5CaO-44.5P(2)O(5)-11Na(2)O (BV11) and 44.5CaO-44.5P(2)O(5)-6Na(2)O-5TiO(2) (G5) were synthesized and treated with silane coupling agent. The glasses obtained were characterized by Microprobe and BET while the efficiency of silanation process was determined using Fourier Transform Infrared Spectroscopy (FTIR), X-ray Photoelectron Spectroscopy (XPS) and Thermal Analysis (DTA and TG) techniques. The content of coupling agent chemically tightly bond to the silanated glasses ascended to 1.69 +/- 0.02 wt % for BV11sil glass and 0.93 +/- 0.01 wt % for G5sil glass. The in vitro bioactivity test carried out in Simulated Body Fluid (SBF) revealed certain bioactive performance with the use of both silanated glasses in a 30% (by weight) as filler of the PMMA composites because of a superficial deposition of an apatite-like layer with low content of CO32- and HPO42- in its structure after soaking for 30 days occurred. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 205-213, 2014.
dc.format.extent9 p.
dc.language.isoeng
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Spain
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.subjectÀrees temàtiques de la UPC::Enginyeria dels materials
dc.subject.lcshBone cements
dc.subject.lcshBiomedical materials
dc.subject.othercalcium phosphate glasses
dc.subject.otherpoly(methyl methacrylate) (PMMA)
dc.subject.othersilane
dc.subject.otherbioactivity
dc.subject.otherbone cements
dc.subject.otherMECHANICAL-PROPERTIES
dc.subject.otherIN-VITRO
dc.subject.otherSOLUBILITY
dc.subject.otherSYSTEM
dc.subject.otherSCAFFOLDS
dc.subject.otherCERAMICS
dc.subject.otherSBF
dc.titleCalcium phosphate glasses: Silanation process and effect on the bioactivity behavior of Glass-PMMA composites
dc.typeArticle
dc.subject.lemacCiments ossis
dc.subject.lemacBiomaterials
dc.contributor.groupUniversitat Politècnica de Catalunya. BBT - Biomaterials, Biomecànica i Enginyeria de Teixits
dc.identifier.doi10.1002/jbm.b.32996
dc.description.peerreviewedPeer Reviewed
dc.relation.publisherversionhttp://onlinelibrary.wiley.com/doi/10.1002/jbm.b.32996/abstract;jsessionid=E307D674B05E7BD17F03113BF7C9026F.f03t04
dc.rights.accessRestricted access - publisher's policy
local.identifier.drac13443194
dc.description.versionPostprint (published version)
dc.date.lift10000-01-01
local.citation.authorMorejon, L.; Delgado, J.; Tarrago, M.; Alvarez, J.; García-Vallès, M.; Martínez, S.; Ginebra, M.P.
local.citation.publicationNameJournal of biomedical materials research. Part B, Applied biomaterials
local.citation.volume102
local.citation.number2
local.citation.startingPage205
local.citation.endingPage213


Fitxers d'aquest items

Imatge en miniatura

Aquest ítem apareix a les col·leccions següents

Mostra el registre d'ítem simple